Pamorelin LA 22.5mg

Pamorelin LA is a medication used to treat various types of cancer, including prostate cancer, breast cancer, and lymphoma. It is an injectable medication that works by stimulating the production of certain hormones that help to slow down the growth of cancer cells.

Composition:

Pamorelin LA contains Triptorelin, a medication that is a gonadotropin-releasing hormone (GnRH) agonist.

Indications:

Pamorelin LA is indicated for the treatment of:

1. Prostate cancer (to reduce the size of the tumor and relieve symptoms)
2. Breast cancer (to reduce the risk of recurrence)
3. Lymphoma (to reduce the risk of recurrence)

Mechanism of Action:

Triptorelin works by:

1. Stimulating the release of certain hormones, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which help to regulate the production of estrogen and testosterone
2. Reducing the production of estrogen and testosterone in the body
3. Inhibiting the growth of cancer cells

Dosage and Administration:

The recommended dosage of Pamorelin LA is:

• 22.5mg injected intramuscularly every 28 days
• The dose should be adjusted based on the patient’s response to treatment and tolerability

Side Effects:

Common side effects of Pamorelin LA include:

1. Hot flashes
2. Flushing
3. Nausea and vomiting
4. Fatigue
5. Headache
6. Dizziness
7. Sleep disturbances
8. Skin rash

Serious side effects can include:

1. Hypogonadism (reduced testosterone levels)
2. Hyperglycemia (high blood sugar)
3. Hypertriglyceridemia (high triglyceride levels)
4. Bone loss
5. Gastrointestinal perforation

Contraindications:

Pamorelin LA is contraindicated in patients with:

1. Hypersensitivity to Triptorelin or other GnRH agonists
2. Pregnancy or breastfeeding
3. Severe liver disease

Precautions:

1. Patients with a history of cardiovascular disease should be closely monitored while receiving Pamorelin LA.
2. Patients with a history of liver disease should be closely monitored while receiving Pamorelin LA.
3. Patients with a history of bone disorders should be closely monitored while receiving Pamorelin LA.

Patient Counseling:

• Patients should be counseled on the importance of taking their medication as directed and not missing doses.
• Patients should be instructed to report any signs of hot flashes or flushing.
• Patients should be advised to report any changes in their appetite or weight loss.

Storage and Handling:

• Store at room temperature (20°C to 25°C) and protected from light.
• Do not freeze or expose to direct sunlight.
• Use within 24 months of opening.

Please note that the dosage and administration information is based on the recommended dosage and may vary depending on individual patient needs and circumstances.